<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">AIDS</journal-id><journal-id journal-id-type="iso-abbrev">AIDS</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">AIDS</journal-id><journal-title-group><journal-title>AIDS (London, England)</journal-title></journal-title-group><issn pub-type="ppub">0269-9370</issn><issn pub-type="epub">1473-5571</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10939916</article-id><article-id pub-id-type="pmcid-ver">PMC10939916.2</article-id><article-id pub-id-type="pmcaid">10939916</article-id><article-id pub-id-type="pmcaiid">10942150</article-id><article-id pub-id-type="pmid">38100633</article-id><article-id pub-id-type="doi">10.1097/QAD.0000000000003817</article-id><article-id pub-id-type="publisher-id">AIDS-D-23-00335</article-id><article-version-alternatives><article-version article-version-type="pmc-version">2</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Epidemiology and Social</subject></subj-group></article-categories><title-group><article-title>Quantifying the association of individual-level characteristics with disparities in kidney transplant waitlist addition among people with HIV</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Shelton</surname><given-names initials="BA">Brittany A.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sen</surname><given-names initials="B">Bisakha</given-names></name><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Becker</surname><given-names initials="DJ">David J.</given-names></name><xref rid="aff3" ref-type="aff">
<sup>c</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>MacLennan</surname><given-names initials="PA">Paul A.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Budhwani</surname><given-names initials="H">Henna</given-names></name><xref rid="aff4" ref-type="aff">
<sup>d</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Locke</surname><given-names initials="JE">Jayme E.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref></contrib></contrib-group><aff id="aff1"><label>a</label>Department of Public Health, University of Tennessee, Knoxville, Tennessee</aff><aff id="aff2"><label>b</label>Heersink School of Medicine</aff><aff id="aff3"><label>c</label>Ryals School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama</aff><aff id="aff4"><label>d</label>College of Nursing, Florida State University, Tallahassee, Florida, USA.</aff><author-notes><corresp>Correspondence to Brittany A. Shelton, DrPH, Assistant Professor, University of Tennessee, Knoxville, 1914 Andy Holt Dr, HPER 372, Knoxville, TN 37996, USA. Tel: +1 865 874 5550; e-mail: <email>Bshelt16@utk.edu</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>13</day><month>12</month><year>2023</year></pub-date><volume>38</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">457980</issue-id><fpage>731</fpage><lpage>737</lpage><history><date date-type="received"><day>11</day><month>6</month><year>2023</year></date><date date-type="rev-recd"><day>04</day><month>12</month><year>2023</year></date><date date-type="accepted"><day>07</day><month>12</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>03</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>16</day><month>03</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-04 15:25:35.543"><day>04</day><month>04</month><year>2025</year></date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10942150</article-id><article-id pub-id-type="doi">10.1097/QAD.0000000000003817</article-id><article-version>2</article-version><pub-date><day>13</day><month>12</month><year>2023</year></pub-date></event><event event-type="pmc-version" specific-use="live"><article-id pub-id-type="pmcaiid">10939916</article-id><article-id pub-id-type="doi">10.1097/QAD.0000000000003817</article-id><article-id pub-id-type="manuscript-id">NIHMS1951514</article-id><article-version>319</article-version><pub-date><day>13</day><month>12</month><year>2023</year></pub-date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2023 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2023</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0</ext-link></license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="aids-38-731.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="aids-38-731.pdf"/><abstract><sec sec-type="background"><title>Background:</title><p>Over 45% of people with HIV (PWH) in the United States at least 50&#8202;years old and are at heightened risk of aging-related comorbidities including end-stage kidney disease (ESKD), for which kidney transplant is the optimal treatment. Among ESKD patients, PWH have lower likelihood of waitlisting, a requisite step in the transplant process, than individuals without HIV. It is unknown what proportion of the inequity by HIV status can be explained by demographics, medical characteristics, substance use history, and geography.</p></sec><sec sec-type="methods"><title>Methods:</title><p>The United States Renal Data System, a national database of all individuals ESKD, was used to create a cohort of people with and without HIV through Medicare claims linkage (2007&#8211;2017). The primary outcome was waitlisting. Inverse odds ratio weighting was conducted to assess what proportion of the disparity by HIV status could be explained by individual characteristics.</p></sec><sec sec-type="results"><title>Results:</title><p>Six thousand two hundred and fifty PWH were significantly younger at ESKD diagnosis and more commonly Black with fewer comorbidities. PWH were more frequently characterized as using tobacco, alcohol and drugs. Positive HIV-status was associated with 57% lower likelihood of waitlisting [adjusted hazard ratio (aHR): 0.43, 95% confidence interval (CI): 0.46&#8211;0.48, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001]. Controlling for demographics, medical characteristics, substance use and geography explained 39.8% of this observed disparity (aHR: 0.69, 95% CI: 0.59&#8211;0.79, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001).</p></sec><sec sec-type="conclusion"><title>Conclusion:</title><p>PWH were significantly less likely to be waitlisted, and 60.2% of that disparity remained unexplained. HIV characteristics such as CD4<sup>+</sup> counts, viral loads, antiretroviral therapy adherence, as well as patient preferences and provider decision-making warrant further study.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>disparities</kwd><kwd>epidemiology</kwd><kwd>HIV</kwd><kwd>kidney disease</kwd><kwd>transplant</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Approximately half of people with HIV (PWH) in the United States are over the age of 50 years [<xref rid="R1" ref-type="bibr">1</xref>], and continued improvements in the efficacy and tolerability of antiretroviral therapies (ART) have enabled PWH to live longer with their HIV diagnosis [<xref rid="R2" ref-type="bibr">2</xref>]. Despite advancements in treatment, PWH may experience rapid biological aging because of both the immune control needed to suppress the HIV virus and the effects of ART regimens [<xref rid="R3" ref-type="bibr">3</xref>]. Consequently, PWH may have a more advanced biological age than chronologic age [<xref rid="R4" ref-type="bibr">4</xref>], and this discrepancy may exceed that observed among people without HIV [<xref rid="R5" ref-type="bibr">5</xref>]. Concerningly, this advanced rate of biological aging is also associated with a greater prevalence of noncommunicable diseases including cardiovascular disease, liver disease, and renal disease at younger ages among PWH than among people without HIV [<xref rid="R4" ref-type="bibr">4</xref>]. As treatment of HIV continues to advance thereby affording greater longevity for PWH, some estimate that by 2035, 44% of older adults with HIV will have three or more noncommunicable diseases and that treatment of these noncommunicable diseases will comprise 56% of total direct HIV care expenditures [<xref rid="R6" ref-type="bibr">6</xref>].</p><p>One noncommunicable disease of pressing concern is kidney disease. Chronic and end-stage kidney disease (ESKD) are leading comorbidities among PWH who may experience increased risk because of HIV viremia, nephrotoxic ART regimens, history of substance use, or co-infection with hepatitis C virus [<xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref>]. Although PWH experience increased risk of chronic kidney disease and rapid progression to ESKD [<xref rid="R9" ref-type="bibr">9</xref>,<xref rid="R10" ref-type="bibr">10</xref>], they are less likely to receive a kidney transplant than people without HIV [<xref rid="R11" ref-type="bibr">11</xref>]. This inequity persists despite the cost-effectiveness and the improved survival afforded by kidney transplantation in comparison to dialysis. Beyond lower likelihood of transplantation, PWH are also less likely to initiate the process of receiving a deceased donor kidney transplant as they experience lower likelihood of referral, evaluation, and waitlisting for transplant [<xref rid="R12" ref-type="bibr">12</xref>&#8211;<xref rid="R15" ref-type="bibr">15</xref>], which are all mandated steps in the deceased donor transplant process. Treatment of ESKD with dialysis costs Medicare and private insurers approximately $40&#8202;000 and $120&#8202;000, respectively per ESKD patient annually [<xref rid="R16" ref-type="bibr">16</xref>], and mortality on dialysis ranges from 5 to 15% annually [<xref rid="R17" ref-type="bibr">17</xref>]. This suggests that the lower rate of transplantation among PWH is associated with significant economic costs and increased mortality.</p><p>The barriers to waitlist addition and to subsequent transplantation for PWH are multifactorial and range from microlevels to macrolevels as illustrated by Socio-Ecological Model for Transplant [<xref rid="R18" ref-type="bibr">18</xref>]. PWH must meet all standard transplant eligibility criteria in addition to HIV-specific criteria such as undetectable HIV viral loads, CD4<sup>+</sup> counts greater than 200&#8202;cells/ml, and the absence of opportunistic infections [<xref rid="R19" ref-type="bibr">19</xref>]. Individual-level factors commonly attributed to the observed disparity include the racial composition of the HIV epidemic [<xref rid="R14" ref-type="bibr">14</xref>], the prevalence of substance use [<xref rid="R13" ref-type="bibr">13</xref>], undernutrition [<xref rid="R20" ref-type="bibr">20</xref>], frailty [<xref rid="R20" ref-type="bibr">20</xref>], and severity of HIV as defined by HIV viral loads and opportunistic infections [<xref rid="R12" ref-type="bibr">12</xref>]. Thus, many hypothesize the convergence of these factors explains disparities in access to the transplant waiting list. Although limited in our ability to examine HIV-specific characteristics given the absence of such data in existing national data sources [<xref rid="R21" ref-type="bibr">21</xref>], we sought to determine what proportion of the disparity in waitlist addition for kidney transplantation could be explained by individual demographics, medical characteristics, history of substance use, and geography. We hypothesized that these individual-level characteristics would fail to completely ameliorate the observed disparity in waitlist addition rates between people with and without HIV.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study population</title><p>This study utilized data from the United States Renal Data System (USRDS), a national database capturing data on all ESKD patients in the United States and their accompanying Medicare claims. Patients were excluded if less than 18&#8202;years of age, first initiated dialysis outside of 01 January 02007 to 31 December 2017, were listed for transplant or transplanted prior to dialysis initiation, died, or were removed from dialysis within 90&#8202;days of dialysis initiation, or had a payer other than Medicare as their insurance payer.</p></sec><sec><title>Exposure of interest</title><p>HIV-status was defined using the Chronic Conditions Data Warehouse definition, requiring one HIV-specific inpatient claim or two nonscreening outpatient claims within a 2-year period [<xref rid="R22" ref-type="bibr">22</xref>]. Given the need for immunosuppressive medications to maintain an organ transplant, HIV-specific criteria for waitlist addition and transplantation exist [<xref rid="R23" ref-type="bibr">23</xref>]. Specifically, PWH who have active AIDS or HIV viremia are not eligible for waitlist addition or subsequent transplantation. Importantly, the ability to identify these characteristics within Medicare claims is limited. To approximate these contraindications, while admittedly not fully encapsulating all HIV-specific waitlist criteria, any PWH with a claim for opportunistic infection within 90&#8202;days of dialysis initiation were excluded to create a more select cohort of PWH [<xref rid="R22" ref-type="bibr">22</xref>].</p></sec><sec><title>Outcome ascertainment</title><p>The primary outcome of this analysis was kidney waitlist addition, the earliest nationally available step in the kidney transplant process, which was analyzed using Cox proportional hazards modeling. Patients began contributing time-at-risk once diagnosed with ESKD and continued to do so until waitlist addition, transplantation, death, or administrative end of study. Patients were censored if they died, received a living donor transplant, or were awaiting waitlist addition/transplantation at the administrative end of study (31 December 2018). Robust standard errors were included for dialysis center.</p></sec><sec><title>Covariates</title><p>Potential explanatory variables were examined in four categories: demographics, medical characteristics, substance use, and geography as captured on the CMS 2728 form. Substance use was defined as tobacco, alcohol, and/or drug dependence, and ascertained through reporting as separate items on the CMS 2728 form. Specifically, individual race, BMI, drug dependence, and rurality were hypothesized to explain substantial proportions of the disparity in waitlist addition between PWH and HIV-negative ESKD patients. A base model for disparity in waitlist addition between PWH and HIV-negative ESKD patients was built, adjusting for HIV status, age at dialysis initiation, year of dialysis initiation, and dialysis center.</p></sec><sec><title>Inverse odds ratio weighting</title><p>To estimate the proportion of the disparity explained by various patient characteristics, inverse odds ratio weighting was conducted [<xref rid="R24" ref-type="bibr">24</xref>,<xref rid="R25" ref-type="bibr">25</xref>]. Inverse odds ratio weighting permits decomposition of an observed disparity into explained and unexplained components. First, a logistic model for HIV status was fitted, adjusted for the base model characteristics and the potential explanatory variable, to generate predicted probabilities. The predicted probabilities were subsequently used to calculate inverse odds ratio weights. The total disparity was estimated through the base model, which employed an unweighted Cox proportional hazards model including HIV status and the base model covariates of age, dialysis center, and year of dialysis initiation. The direct effect was calculated through a weighted Cox proportional hazards model that incorporated the inverse odds ratio weights. This direct effect represented the reduction in disparity observed if the observable characteristics were similar between PWH and HIV-negative ESKD patients. Comparison of the total and direct effects permitted calculation of the percentage of the disparity that could be explained by differences in the patient characteristics. Standard errors were calculated via bootstrapping with 1000 replications. As a sensitivity analysis, we replicated these analyses in a cohort of incident ESKD patients from 2012 to 2017.</p><p>Statistical analyses were conducted in SAS 9.4 (Cary, North Carolina, USA) and Stata 15.1 (College Station, Texas, USA). All statistical analyses were conducted with two-sided significance at an alpha of less than 0.05.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Demographics</title><p>In this cohort, there were 6250 PWH and 595&#8202;756 HIV-negative ESKD patients. There were numerous meaningful differences between the two groups (Table <xref rid="T1" ref-type="table">1</xref>). PWH were more commonly African American/Black (heretofore referred to as Black) as compared with HIV-negative ESKD patients (70.0 vs. 26.7%, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001, SD: 0.96). They were less commonly women (31.7 vs. 43.4%, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001, SD: &#8722;0.24) and less commonly Hispanic (12.9 vs. 10%, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001, SD: &#8722;0.11). A significantly higher proportion of PWH had a BMI less than 18.5&#8202;kg/m<sup>2</sup>, corresponding to an underweight status (6.4 vs. 3.1%, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001, SD: 0.16). There was a higher prevalence of reported drug dependence among PWH as compared with HIV-negative ESKD patients (7.8 vs. 1.0%, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001, SD: 0.11). Last, PWH less commonly lived in rural areas than HIV-negative ESKD patients (0.9 vs. 3.3%, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001, SD: &#8722;0.17).</p><table-wrap position="float" id="T1" orientation="portrait"><label>Table 1</label><caption><p>Patient-level characteristics by HIV status at time of end-stage kidney disease diagnosis.</p></caption><table frame="hsides" rules="groups" border="0"><thead><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">HIV&#8722;</td><td align="center" rowspan="1" colspan="1">HIV+</td><td align="center" rowspan="1" colspan="1"><italic toggle="yes">P</italic> value</td><td align="center" rowspan="1" colspan="1">Std. Diff</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Characteristic</td><td align="center" rowspan="1" colspan="1"><italic toggle="yes">N</italic>&#8202;=&#8202;595&#8202;756</td><td align="center" rowspan="1" colspan="1"><italic toggle="yes">N</italic>&#8202;=&#8202;6250</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" colspan="5" rowspan="1">Demographics</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Age at ESKD diagnosis</td><td align="center" rowspan="1" colspan="1">65 (55&#8211;75)</td><td align="center" rowspan="1" colspan="1">51 (43&#8211;60)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">&#8722;0.99</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Female</td><td align="center" rowspan="1" colspan="1">258&#8202;260 (43.4)</td><td align="center" rowspan="1" colspan="1">1982 (31.7)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">&#8722;0.24</td></tr><tr><td align="left" colspan="5" rowspan="1">&#8195;Race</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;White</td><td align="center" rowspan="1" colspan="1">402&#8202;095 (67.5)</td><td align="center" rowspan="1" colspan="1">1717 (27.5)</td><td align="center" rowspan="1" colspan="1">&lt;0.001<break/>&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">&#8722;0.87</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;African American/Black</td><td align="center" rowspan="1" colspan="1">159&#8202;037 (26.7)</td><td align="center" rowspan="1" colspan="1">4376 (70.0)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.96</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;American Indian/Alaskan Native</td><td align="center" rowspan="1" colspan="1">7001 (1.2)</td><td align="center" rowspan="1" colspan="1">66 (1.1)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Asian</td><td align="center" rowspan="1" colspan="1">20&#8202;086 (3.4)</td><td align="center" rowspan="1" colspan="1">53 (0.9)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.18</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Native Hawaiian/Pacific Islander</td><td align="center" rowspan="1" colspan="1">5784 (1.0)</td><td align="center" rowspan="1" colspan="1">21 (0.3)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.08</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Ethnicity&#8202;=&#8202;Hispanic</td><td align="center" rowspan="1" colspan="1">75&#8202;791 (12.9)</td><td align="center" rowspan="1" colspan="1">618 (10.0)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.09</td></tr><tr><td align="left" colspan="5" rowspan="1">Medical comorbidities</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;BMI</td><td align="center" rowspan="1" colspan="1">28.2 (24.0&#8211;33.8)</td><td align="center" rowspan="1" colspan="1">25.4 (21.8&#8211;30.4)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">&#8722;0.34</td></tr><tr><td align="left" colspan="5" rowspan="1">&#8195;BMI class</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;&lt;18.5</td><td align="center" rowspan="1" colspan="1">18&#8202;139 (3.1)</td><td align="center" rowspan="1" colspan="1">393 (6.4)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;18.5&#8211;24.9</td><td align="center" rowspan="1" colspan="1">167&#8202;183 (28.6)</td><td align="center" rowspan="1" colspan="1">2499 (40.9)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.26</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;25&#8211;29.9</td><td align="center" rowspan="1" colspan="1">164&#8202;852 (28.2)</td><td align="center" rowspan="1" colspan="1">1604 (26.2)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;30&#8211;34.9</td><td align="center" rowspan="1" colspan="1">111&#8202;337 (19.1)</td><td align="center" rowspan="1" colspan="1">847 (13.9)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;35&#8211;39.9</td><td align="center" rowspan="1" colspan="1">61&#8202;742 (10.6)</td><td align="center" rowspan="1" colspan="1">396 (6.5)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;&#8805;40</td><td align="center" rowspan="1" colspan="1">60&#8202;646 (10.4)</td><td align="center" rowspan="1" colspan="1">374 (6.1)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.16</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Diabetes</td><td align="center" rowspan="1" colspan="1">236&#8202;086 (40.4)</td><td align="center" rowspan="1" colspan="1">1534 (25.4)</td><td rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">&#8722;0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hypertension</td><td align="center" rowspan="1" colspan="1">515&#8202;766 (88.2)</td><td align="center" rowspan="1" colspan="1">5138 (85.0)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">&#8722;0.10</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Alcohol dependence</td><td align="center" rowspan="1" colspan="1">8151 (1.4)</td><td align="center" rowspan="1" colspan="1">183 (3.0)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Drug dependence</td><td align="center" rowspan="1" colspan="1">5787 (1.0)</td><td align="center" rowspan="1" colspan="1">469 (7.8)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Cancer</td><td align="center" rowspan="1" colspan="1">42&#8202;974 (7.4)</td><td align="center" rowspan="1" colspan="1">205 (3.4)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">&#8722;0.18</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Needs assistance with daily activities</td><td align="center" rowspan="1" colspan="1">75&#8202;512 (12.9)</td><td align="center" rowspan="1" colspan="1">520 (8.6)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">&#8722;0.14</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Tobacco use</td><td align="center" rowspan="1" colspan="1">38&#8202;414 (6.6)</td><td align="center" rowspan="1" colspan="1">769 (12.7)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">0.21</td></tr><tr><td align="left" colspan="5" rowspan="1">Geography</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Rural</td><td align="center" rowspan="1" colspan="1">19&#8202;549 (3.3)</td><td align="center" rowspan="1" colspan="1">56 (0.9)</td><td align="center" rowspan="1" colspan="1">&lt;0.001</td><td align="char" char="." rowspan="1" colspan="1">&#8722;0.17</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>ESKD, end-stage kidney disease.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Demographic variables</title><p>In the base model, HIV status was associated with 57% lower likelihood of waitlist addition [adjusted hazard ratio (aHR): 0.43, 95% CI: 0.46&#8211;0.48, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; Table <xref rid="T2" ref-type="table">2</xref>]. 32.3% of this observed disparity could be explained by race (aHR: 0.64, 95% CI: 0.59&#8211;0.69, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001). Sex and Hispanic ethnicity independently explained a smaller proportion of the observed disparity (aHR: 0.57, 95% CI: 0.51&#8211;0.63, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; aHR: 0.59, 95% CI: 0.52&#8211;0.62, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001). When assessing the demographic characteristics of race, sex, and ethnicity simultaneously, 32.6% of the observed disparity in waitlist addition could be explained by these factors (aHR: 0.64, 95% CI: 0.62&#8211;0.67, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001) (Table <xref rid="T3" ref-type="table">3</xref>), and the remaining 67.4% of the disparity remained unexplained by demographic characteristics.</p><table-wrap position="float" id="T2" orientation="portrait"><label>Table 2</label><caption><p>Decomposition of disparity in waitlist addition by individual characteristics.</p></caption><table frame="hsides" rules="groups" border="0"><thead><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">aHR (95% CI) for HIV-status</td><td align="center" rowspan="1" colspan="1">Percent attributable</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Base model<sup>a</sup></td><td align="char" char="(" rowspan="1" colspan="1">0.47 (0.46&#8211;0.48)</td><td align="center" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" colspan="3" rowspan="1">Demographics</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Sex</td><td align="char" char="(" rowspan="1" colspan="1">0.57 (0.51&#8211;0.63)</td><td align="center" rowspan="1" colspan="1">17.7%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Race</td><td align="char" char="(" rowspan="1" colspan="1">0.64 (0.59&#8211;0.69)</td><td align="center" rowspan="1" colspan="1">32.3%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hispanic/Latinx</td><td align="char" char="(" rowspan="1" colspan="1">0.59 (0.56&#8211;0.62)</td><td align="center" rowspan="1" colspan="1">22.0%</td></tr><tr><td align="left" colspan="3" rowspan="1">Medical characteristics</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;BMI</td><td align="char" char="(" rowspan="1" colspan="1">0.59 (0.52&#8211;0.68)</td><td align="center" rowspan="1" colspan="1">23.2%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Diabetes</td><td align="char" char="(" rowspan="1" colspan="1">0.60 (0.56&#8211;0.64)</td><td align="center" rowspan="1" colspan="1">23.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hypertension</td><td align="char" char="(" rowspan="1" colspan="1">0.59 (0.53&#8211;0.67)</td><td align="center" rowspan="1" colspan="1">22.8%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Ischemic heart disease</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.54&#8211;0.62)</td><td align="center" rowspan="1" colspan="1">20.3%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Myocardial infarction</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.50&#8211;0.67)</td><td align="center" rowspan="1" colspan="1">20.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Cardiac arrest</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.53&#8211;0.63)</td><td align="center" rowspan="1" colspan="1">20.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Dysrhythmia</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.53&#8211;0.62)</td><td align="center" rowspan="1" colspan="1">20.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Pericarditis</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.52&#8211;0.64)</td><td align="center" rowspan="1" colspan="1">20.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Congestive heart failure</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.52&#8211;0.64)</td><td align="center" rowspan="1" colspan="1">20.2%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Peripheral vascular disease</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.53&#8211;0.63)</td><td align="center" rowspan="1" colspan="1">20.6%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Cancer</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.53&#8211;0.65)</td><td align="center" rowspan="1" colspan="1">21.2%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Inambulatory</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.51&#8211;0.67)</td><td align="center" rowspan="1" colspan="1">21.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Amputation</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.50&#8211;0.68)</td><td align="center" rowspan="1" colspan="1">21.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Needs assistance with daily activities</td><td align="char" char="(" rowspan="1" colspan="1">0.58 (0.50&#8211;0.680</td><td align="center" rowspan="1" colspan="1">21.0%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Institutionalized</td><td align="char" char="(" rowspan="1" colspan="1">0.59 (0.54&#8211;0.64)</td><td align="center" rowspan="1" colspan="1">22.3%</td></tr><tr><td align="left" colspan="3" rowspan="1">Substance use</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Alcohol dependence</td><td align="char" char="(" rowspan="1" colspan="1">0.59 (0.50&#8211;0.70)</td><td align="center" rowspan="1" colspan="1">22.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Drug dependence</td><td align="char" char="(" rowspan="1" colspan="1">0.61 (0.59&#8211;0.64)</td><td align="center" rowspan="1" colspan="1">26.2%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Tobacco use</td><td align="char" char="(" rowspan="1" colspan="1">0.61 (0.55&#8211;0.67)</td><td align="center" rowspan="1" colspan="1">25.5%</td></tr><tr><td align="left" colspan="3" rowspan="1">Geography</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Rural</td><td align="char" char="(" rowspan="1" colspan="1">0.59 (0.53&#8211;0.66)</td><td align="center" rowspan="1" colspan="1">22.3%</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;UNOS Region</td><td align="char" char="(" rowspan="1" colspan="1">0.57 (0.54&#8211;0.61)</td><td align="center" rowspan="1" colspan="1">19.4%</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>Indirect &#8211; amount disparity would be reduced if equivalent. aHR, adjusted hazards ratio; CI, confidence interval.</p></fn><fn fn-type="other" id="T2fn1"><label>a</label><p>Adjusted for HIV status, age at dialysis initiation, ESKD diagnosis year, dialysis center.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3" orientation="portrait"><label>Table 3</label><caption><p>Decomposition of observed disparity by groups of characteristics.</p></caption><table frame="hsides" rules="groups" border="0"><thead><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">aHR (95% CI) for HIV-status</td><td align="center" rowspan="1" colspan="1">Percent attributable</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Base model<sup>a</sup></td><td align="char" char="(" rowspan="1" colspan="1">0.47 (0.46&#8211;0.48)</td><td align="char" char="." rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" rowspan="1" colspan="1">Demographics</td><td align="char" char="(" rowspan="1" colspan="1">0.64 (0.62&#8211;0.67)</td><td align="char" char="." rowspan="1" colspan="1">32.6%</td></tr><tr><td align="left" rowspan="1" colspan="1">Medical characteristics</td><td align="char" char="(" rowspan="1" colspan="1">0.60 (0.55&#8211;0.65)</td><td align="char" char="." rowspan="1" colspan="1">24.3%</td></tr><tr><td align="left" rowspan="1" colspan="1">Substance use</td><td align="char" char="(" rowspan="1" colspan="1">0.62 (0.57&#8211;0.68)</td><td align="char" char="." rowspan="1" colspan="1">28.4%</td></tr><tr><td align="left" rowspan="1" colspan="1">Geography</td><td align="char" char="(" rowspan="1" colspan="1">0.59 (0.53&#8211;0.64)</td><td align="char" char="." rowspan="1" colspan="1">22.4%</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>aHR, adjusted hazards ratio; CI, confidence interval.</p></fn><fn fn-type="other" id="T3fn1"><label>a</label><p>Adjusted for HIV status, age at dialysis initiation, ESKD diagnosis year, dialysis center.</p></fn></table-wrap-foot></table-wrap></sec><sec><title>Medical characteristics</title><p>The primary medical characteristic of interest was BMI. Accounting for BMI explained 23.2% of the observed disparity in waitlist addition (aHR: 0.59, 95% CI: 0.52&#8211;0.68, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; Table <xref rid="T2" ref-type="table">2</xref>). Diabetes and hypertension explained 23.4 and 22.8% of the disparity, respectively (aHR: 0.60, 95% CI: 0.54&#8211;0.66, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; aHR: 0.59, 95% CI: 0.53&#8211;0.67, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001). Examining these medical characteristics together with cardiovascular conditions and functional status explained 24.3% of the observed disparity with the remaining 75.7% unexplained by medical characteristics (aHR: 0.60, 95% CI: 0.55&#8211;0.65, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; Table <xref rid="T3" ref-type="table">3</xref>).</p></sec><sec><title>Substance use</title><p>The primary substance use characteristic of interest was drug dependence, which accounted for 26.4% of the observed disparity (aHR: 0.61, 95% CI: 0.59&#8211;0.64, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001). Alcohol dependence and tobacco use explained 22.4 and 25.5% of the observed disparity, respectively (aHR: 0.59, 95% CI: 0.50&#8211;0.70, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; aHR: 0.61, 95% CI: 0.55&#8211;0.67, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001). Moreover, accounting for alcohol use, drug dependence, and tobacco use simultaneously accounted for 28.4% of the observed disparity, and the remaining 71.6% of the disparity was unexplained by characteristics specific to substance use (aHR: 0.62, 95% CI: 0.57&#8211;0.68, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; Table <xref rid="T3" ref-type="table">3</xref>).</p></sec><sec><title>Geography</title><p>The primary geographical measure of interest was rurality, which accounted for 22.3% of the observed disparity (aHR: 0.59, 95% CI: 0.53&#8211;0.66, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; Table <xref rid="T2" ref-type="table">2</xref>). United Network for Organ Sharing (UNOS) Region alone explained 19.4% of the disparity (aHR: 0.57, 95% CI: 0.54&#8211;0.61, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001). Examining both UNOS Region and rurality together, geography accounted for 22.4% of the observed disparity, with 78.9% remaining unexplained by characteristics specific to patient geographic location (aHR: 0.59, 95% CI: 0.53&#8211;0.64, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; Table <xref rid="T3" ref-type="table">3</xref>).</p></sec><sec><title>Combined domains</title><p>Together, demographics and substance use explained 36.6% of the observed disparity (aHR: 0.67, 95% CI: 0.62&#8211;0.72, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001). The addition of the geography domain to the demographics and substance use domains increased the amount of the disparity explained to 38.6% (aHR: 0.68, 95% CI: 0.62&#8211;0.74, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001). Accounting for the four domains of demographics, medical characteristics, substance use, and geography together explained 39.8% of the observed disparity in waitlist addition between PWH and HIV-negative ESKD patients (aHR: 0.69, 95% CI: 0.59&#8211;0.79, <italic toggle="yes">P</italic>&#8202;&lt;&#8202;0.001; Table <xref rid="T4" ref-type="table">4</xref>). The remaining 60.2% of the disparity remained unexplained by these observed characteristics.</p><table-wrap position="float" id="T4" orientation="portrait"><label>Table 4</label><caption><p>Decomposition of disparity by multiple groups of characteristics.</p></caption><table frame="hsides" rules="groups" border="0"><thead><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">aHR (95% CI) for HIV status</td><td align="center" rowspan="1" colspan="1">Percent attributable</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Base model<sup>a</sup></td><td align="char" char="(" rowspan="1" colspan="1">0.47 (0.46&#8211;0.48)</td><td align="center" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" rowspan="1" colspan="1">Demographics + substance use</td><td align="char" char="(" rowspan="1" colspan="1">0.67 (0.62&#8211;0.72)</td><td align="center" rowspan="1" colspan="1">36.6%</td></tr><tr><td align="left" rowspan="1" colspan="1">Medical comorbidities + substance use</td><td align="char" char="(" rowspan="1" colspan="1">0.64 (0.60&#8211;0.68)</td><td align="center" rowspan="1" colspan="1">31.2%</td></tr><tr><td align="left" rowspan="1" colspan="1">Demographics + substance use + geography</td><td align="char" char="(" rowspan="1" colspan="1">0.68 (0.62&#8211;0.74)</td><td align="center" rowspan="1" colspan="1">38.6%</td></tr><tr><td align="left" rowspan="1" colspan="1">Demographics + medical Characteristics + substance use + geography</td><td align="char" char="(" rowspan="1" colspan="1">0.69 (0.59&#8211;0.79)</td><td align="center" rowspan="1" colspan="1">39.8%</td></tr></tbody></table><table-wrap-foot><fn fn-type="other"><p>aHR, adjusted hazards ratio; CI, confidence interval.</p></fn><fn fn-type="other" id="T4fn1"><label>a</label><p>Adjusted for HIV status, age at dialysis initiation, ESKD diagnosis year, dialysis center.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In this national study of ESKD patients, positive HIV status was associated with significantly lower likelihood of addition to the kidney transplant waitlist. Given the cause of HIV and requirements for waitlist addition, there were multiple factors hypothesized to explain this disparity including race, BMI, and active substance use. Individually, race explained 32.3% of the disparity, and drug dependence explained 26.4% of the disparity, which were the two strongest effects. In totality, accounting for differences in demographics, medical characteristics, substance use, and geography as domains of variables explained a total of 39.8% of the observed disparity, leaving 60.2% of the disparity unexplained by observed characteristics.</p><p>Race was the strongest single contributor to the disparity in waitlist addition. Undoubtedly, some of the remaining disparity could be attributable to HIV-specific characteristics, such as viral loads and CD4<sup>+</sup> counts, for which we could not account, and the inability to control for these factors likely impacts our inferences with respect to race as documentation of sustained viral suppression and high CD4<sup>+</sup> counts are necessary for successful transplant evaluation and subsequent waitlist addition. Black PWH have markedly lower rates of viral suppression and ART adherence than white PWH, and HIV stigma, which interacts with anti-Black racism [<xref rid="R26" ref-type="bibr">26</xref>&#8211;<xref rid="R28" ref-type="bibr">28</xref>], has been implicated in lower rates of viral suppression and ART adherence, critical factors for progressing through the kidney transplant process. Additionally, although some studies have suggested socioeconomic status may explain racial disparities in waitlist addition, among a cohort of ESKD patients in Baltimore, socioeconomic status and comorbidities explained only 58% of inequities in waitlist addition, rendering 42% unexplained.&#8216; Thus, perceived discrimination, structural racism, and implicit bias also warrant consideration [<xref rid="R29" ref-type="bibr">29</xref>]. Factors such as medical mistrust, financial restraints, and scheduling difficulties may also impede completion of transplant evaluation and subsequent waitlist addition among Black ESKD patients [<xref rid="R30" ref-type="bibr">30</xref>]. Although multiple interventions have been developed to assist Black ESKD patients throughout the transplant process, these interventions may need tailoring to meet the unique needs of Black PWH whose evaluation process will require greater collaboration between their HIV providers and transplant providers [<xref rid="R31" ref-type="bibr">31</xref>&#8211;<xref rid="R34" ref-type="bibr">34</xref>]. Consequently, greater research into the intersectionality of these two identities, the resulting ability to engage in care, and the need for supportive ESKD care is needed.</p><p>Medical characteristics, specifically BMI, and substance use together explained 31.2% of the observed disparity, which is consistent with hypotheses posited by previous studies [<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R20" ref-type="bibr">20</xref>]. Low BMI and frailty are both associated with suboptimal patient outcomes among PWH, such as HIV disease progression and mortality, and is also associated with substance use [<xref rid="R35" ref-type="bibr">35</xref>,<xref rid="R36" ref-type="bibr">36</xref>]. In a cohort of French ESKD patients, substance use was more prevalent among PWH and likely contributed to the observed lower rates of waitlist addition among PWH [<xref rid="R20" ref-type="bibr">20</xref>]. Consistent with that study, a recent single-center study in the United States also observed high rates of active substance use, the largest reason for ineligibility for waitlist addition. Nationally, substance use, including tobacco, alcohol, and drug dependence, has been associated with 61% lower likelihood of waitlist addition among all ESKD patients, and active substance use is associated with disproportionately lower rates of waitlist addition when occurring among Black and Hispanic patients [<xref rid="R37" ref-type="bibr">37</xref>]. Given center-level desires to maximize patient outcomes, this disparity may reflect provider concerns that patients engaging in substance use are less likely to be adherent to immunosuppressive regimens posttransplant [<xref rid="R38" ref-type="bibr">38</xref>], and it is plausible such concerns would be amplified among PWH who must also remain adherent to their ART regimens.</p><p>There are multiple omitted factors; however, that may further explain the observed disparities including patient preference, provider knowledge, environmental factors, and policies. Similarly, provider knowledge is associated with waitlist addition rates [<xref rid="R39" ref-type="bibr">39</xref>]. Given the relatively recent advent of transplantation in this patient population, it is perhaps possible that increasing provider knowledge about transplantation among PWH, could yield higher referral and waitlisting rates. Numerous studies have demonstrated that facility-level characteristics such as Medicare dialysis facility quality rating, ownership status, and center philosophy impact likelihood of waitlist addition and thus, these characteristics may explain some of the remaining unexplained disparity [<xref rid="R40" ref-type="bibr">40</xref>&#8211;<xref rid="R42" ref-type="bibr">42</xref>]. Nationally, Medicaid expansion has been associated with increased waitlist addition rates and improved survival on dialysis [<xref rid="R43" ref-type="bibr">43</xref>,<xref rid="R44" ref-type="bibr">44</xref>]. As Medicaid has not yet been expanded in many states in the Southeast region of the United States where HIV and ESKD burdens are greatest, this may be particularly pertinent. Moreover, little is known about the role of HIV criminalization laws or, conversely, nondiscrimination laws for sexual and gender minorities in engagement with care for ESKD. In particularly, HIV criminalization laws may be worthy of study, given their association with increased stigma and decreased medical trust [<xref rid="R28" ref-type="bibr">28</xref>,<xref rid="R45" ref-type="bibr">45</xref>], critical barriers to participation in the kidney transplant process. These institutional-level and policy-level factors warrant greater study to disentangle their role in creating and exacerbating barriers to waitlist addition for PWH.This study is subject to multiple limitations. Most importantly, we lack access to HIV-specific characteristics such as HIV viral loads, CD4<sup>+</sup> counts, and ART regimens, which likely contribute to some of the unexplained disparity. Despite this limitation, numerous studies with access to those data have also found lower rates of waitlist addition that were not mitigated through formation of a more select group of PWH [<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>,<xref rid="R20" ref-type="bibr">20</xref>]. Thus, while our findings may be overestimated, they are likely still valid. As this was a retrospective study, we are limited in what characteristics we could consider. Consequently, we could not examine the role of perceived racism, HIV stigma, health literacy, referral patterns, or knowledge of transplant. Because all ESKD patients in this study utilized Medicare as their primary payer, we were unable to use insurance status as a surrogate for socioeconomic status. Thus, future work is needed to capture</p><p>social determinants of health including income, employment status, discrimination, and stress. Despite these limitations, this study provides valuable information on the extent to which observed patient demographics, medical characteristics, history of substance use, and geography can explain the observed disparity in waitlist addition between PWH and HIV-negative ESKD patients.</p><p>In conclusion, the combination of demographics, medical characteristics, substance use, and geography explained 39.8% of the disparity in waitlist addition between PWH and HIV-negative ESKD patients. As a result, efforts to increase waitlist addition for racial minorities and to address substance use may mitigate some of the disparity between these two groups. Greater work is needed to identify whether characteristics such as viremia, ART adherence, provider referral patterns, racism, and HIV stigma may explain the remaining 60.2% of the disparity.</p></sec><sec><title>Acknowledgements</title><p>Sources of funding: this work was supported by the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK117675, PI: Locke) and National Institute of Mental Health (K01 MH116737, PI: Budhwani).</p><p>Disclaimer: the data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the authors and in no way should be seen as an official policy or interpretation of the US government.</p><sec sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="book"><comment>Centers for Disease Control and Prevention. The state of the HIV epidemic in the U.S. Available at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/state-of-the-hiv-epidemic-factsheet.html" ext-link-type="uri">https://www.cdc.gov/nchhstp/newsroom/fact-sheets/hiv/state-of-the-hiv-epidemic-factsheet.html</ext-link>. [Accessed 15 May 2023]</comment></mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smit</surname><given-names>M</given-names></name><name name-style="western"><surname>Brinkman</surname><given-names>K</given-names></name><name name-style="western"><surname>Geerlings</surname><given-names>S</given-names></name><name name-style="western"><surname>Smit</surname><given-names>C</given-names></name><name name-style="western"><surname>Thyagarajan</surname><given-names>K</given-names></name><name name-style="western"><surname>Sighem</surname><given-names>Av</given-names></name><etal/></person-group>. <collab>ATHENA observational cohort</collab>. <article-title>Future challenges for clinical care of an ageing population infected with HIV: a modelling study</article-title>. <source><italic toggle="yes">Lancet Infect Dis</italic></source><year>2015</year>; <volume>15</volume>:<fpage>810</fpage>&#8211;<lpage>818</lpage>.<pub-id pub-id-type="pmid">26070969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1473-3099(15)00056-0</pub-id><pub-id pub-id-type="pmcid">PMC4528076</pub-id></mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thurman</surname><given-names>M</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>S</given-names></name><name name-style="western"><surname>Acharya</surname><given-names>A</given-names></name><name name-style="western"><surname>Pallikkuth</surname><given-names>S</given-names></name><name name-style="western"><surname>Mahesh</surname><given-names>M</given-names></name><name name-style="western"><surname>Byrareddy</surname><given-names>SN</given-names></name></person-group>. <article-title>Biomarkers of activation and inflammation to track disparity in chronological and physiological age of people living with HIV on combination antiretroviral therapy</article-title>. <source><italic toggle="yes">Front Immunol</italic></source><year>2020</year>; <volume>11</volume>:<fpage>583934</fpage>.<pub-id pub-id-type="pmid">33162998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.583934</pub-id><pub-id pub-id-type="pmcid">PMC7581935</pub-id></mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pathai</surname><given-names>S</given-names></name><name name-style="western"><surname>Bajillan</surname><given-names>H</given-names></name><name name-style="western"><surname>Landay</surname><given-names>AL</given-names></name><name name-style="western"><surname>High</surname><given-names>KP</given-names></name></person-group>. <article-title>Is HIV a model of accelerated or accentuated aging?</article-title>. <source><italic toggle="yes">J Gerontol A Biol Sci Med Sci</italic></source><year>2014</year>; <volume>69</volume>:<fpage>833</fpage>&#8211;<lpage>842</lpage>.<pub-id pub-id-type="pmid">24158766</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/gerona/glt168</pub-id><pub-id pub-id-type="pmcid">PMC4067117</pub-id></mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Francesco</surname><given-names>D</given-names></name><name name-style="western"><surname>Wit</surname><given-names>FW</given-names></name><name name-style="western"><surname>B&#252;rkle</surname><given-names>A</given-names></name><name name-style="western"><surname>Oehlke</surname><given-names>S</given-names></name><name name-style="western"><surname>Kootstra</surname><given-names>NA</given-names></name><name name-style="western"><surname>Winston</surname><given-names>A</given-names></name><etal/></person-group>. <collab>the Co-morBidity in Relation to AIDS (COBRA) Collaboration</collab>. <article-title>Do people living with HIV experience greater age advancement than their HIV-negative counterparts?</article-title>. <source><italic toggle="yes">Aids</italic></source><year>2019</year>; <volume>33</volume>:<fpage>259</fpage>&#8211;<lpage>268</lpage>.<pub-id pub-id-type="pmid">30325781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002063</pub-id><pub-id pub-id-type="pmcid">PMC6319574</pub-id></mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smit</surname><given-names>M</given-names></name><name name-style="western"><surname>Cassidy</surname><given-names>R</given-names></name><name name-style="western"><surname>Cozzi-Lepri</surname><given-names>A</given-names></name><name name-style="western"><surname>Quiros-Roldan</surname><given-names>E</given-names></name><name name-style="western"><surname>Girardi</surname><given-names>E</given-names></name><name name-style="western"><surname>Mammone</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Projections of noncommunicable disease and healthcare costs among HIV-positive persons in Italy and the U.S.A.: A modelling study</article-title>. <source><italic toggle="yes">PLoS One</italic></source><year>2017</year>; <volume>12</volume>:<fpage>e0186638</fpage>.<pub-id pub-id-type="pmid">29059202</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0186638</pub-id><pub-id pub-id-type="pmcid">PMC5653300</pub-id></mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>FM</given-names></name><name name-style="western"><surname>Wu</surname><given-names>J</given-names></name><name name-style="western"><surname>Jansson</surname><given-names>J</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>DP</given-names></name></person-group>. <article-title>Relative risk of renal disease among people living with HIV: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">BMC Public Health</italic></source><year>2012</year>; <volume>12</volume>:<fpage>234</fpage>.<pub-id pub-id-type="pmid">22439731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2458-12-234</pub-id><pub-id pub-id-type="pmcid">PMC3402981</pub-id></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shelton</surname><given-names>BA</given-names></name><name name-style="western"><surname>Sawinski</surname><given-names>D</given-names></name><name name-style="western"><surname>MacLennan</surname><given-names>PA</given-names></name><name name-style="western"><surname>Lee</surname><given-names>W</given-names></name><name name-style="western"><surname>Wyatt</surname><given-names>C</given-names></name><name name-style="western"><surname>Nadkarni</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: a longitudinal, multicentre, cohort study</article-title>. <source><italic toggle="yes">EClinicalMedicine</italic></source><year>2022</year>; <volume>53</volume>:<fpage>101653</fpage>.<pub-id pub-id-type="pmid">36159042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eclinm.2022.101653</pub-id><pub-id pub-id-type="pmcid">PMC9489495</pub-id></mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lucas</surname><given-names>GM</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>SH</given-names></name><name name-style="western"><surname>Atta</surname><given-names>MG</given-names></name><name name-style="western"><surname>Kirk</surname><given-names>GD</given-names></name><name name-style="western"><surname>Galai</surname><given-names>N</given-names></name><name name-style="western"><surname>Vlahov</surname><given-names>D</given-names></name><name name-style="western"><surname>Moore</surname><given-names>RD</given-names></name></person-group>. <article-title>End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004</article-title>. <source><italic toggle="yes">Aids</italic></source><year>2007</year>; <volume>21</volume>:<fpage>2435</fpage>&#8211;<lpage>2443</lpage>.<pub-id pub-id-type="pmid">18025880</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0b013e32827038ad</pub-id></mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bansi</surname><given-names>L</given-names></name><name name-style="western"><surname>Hughes</surname><given-names>A</given-names></name><name name-style="western"><surname>Bhagani</surname><given-names>S</given-names></name><name name-style="western"><surname>Mackie</surname><given-names>NE</given-names></name><name name-style="western"><surname>Leen</surname><given-names>C</given-names></name><name name-style="western"><surname>Levy</surname><given-names>J</given-names></name><etal/></person-group>. <collab>UK CHIC/ESRF study group</collab>. <article-title>Clinical epidemiology of HIV-associated end-stage renal failure in the UK</article-title>. <source><italic toggle="yes">AIDS</italic></source><year>2009</year>; <volume>23</volume>:<fpage>2517</fpage>&#8211;<lpage>2521</lpage>.<pub-id pub-id-type="pmid">19752713</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0b013e3283320e12</pub-id></mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locke</surname><given-names>JE</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>S</given-names></name><name name-style="western"><surname>Sawinski</surname><given-names>D</given-names></name><name name-style="western"><surname>Gustafson</surname><given-names>S</given-names></name><name name-style="western"><surname>Shelton</surname><given-names>BA</given-names></name><name name-style="western"><surname>Reed</surname><given-names>RD</given-names></name><etal/></person-group>. <article-title>Access to Kidney transplantation among HIV-infected waitlist candidates</article-title>. <source><italic toggle="yes">Clin J Am Soc Nephrol</italic></source><year>2017</year>; <volume>12</volume>:<fpage>467</fpage>&#8211;<lpage>475</lpage>.<pub-id pub-id-type="pmid">28232406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2215/CJN.07460716</pub-id><pub-id pub-id-type="pmcid">PMC5338712</pub-id></mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><name name-style="western"><surname>Fehr</surname><given-names>K</given-names></name><name name-style="western"><surname>Deering</surname><given-names>C</given-names></name><name name-style="western"><surname>Raza</surname><given-names>A</given-names></name><name name-style="western"><surname>Harhay</surname><given-names>MN</given-names></name><name name-style="western"><surname>Malat</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Barriers to kidney transplant evaluation in HIV-positive patients with advanced kidney disease: a single-center study</article-title>. <source><italic toggle="yes">Transpl Infect Dis</italic></source><year>2020</year>; <volume>22</volume>:<fpage>e13253</fpage>.<pub-id pub-id-type="pmid">31994821</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/tid.13253</pub-id><pub-id pub-id-type="pmcid">PMC7162707</pub-id></mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>DH</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><name name-style="western"><surname>Malat</surname><given-names>GE</given-names></name><name name-style="western"><surname>Kern</surname><given-names>C</given-names></name><name name-style="western"><surname>Milrod</surname><given-names>C</given-names></name><name name-style="western"><surname>DeBellis</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Barriers to listing for HIV-infected patients being evaluated for kidney transplantation</article-title>. <source><italic toggle="yes">Transpl Infect Dis</italic></source><year>2017</year>; <volume>19</volume>:<fpage>12777</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/tid.12777</pub-id><pub-id pub-id-type="pmcid">PMC5745286</pub-id><pub-id pub-id-type="pmid">28921783</pub-id></mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sawinski</surname><given-names>D</given-names></name><name name-style="western"><surname>Wyatt</surname><given-names>CM</given-names></name><name name-style="western"><surname>Casagrande</surname><given-names>L</given-names></name><name name-style="western"><surname>Myoung</surname><given-names>P</given-names></name><name name-style="western"><surname>Bijan</surname><given-names>I</given-names></name><name name-style="western"><surname>Akalin</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Factors associated with failure to list HIV-positive kidney transplant candidates</article-title>. <source><italic toggle="yes">Am J Transplant</italic></source><year>2009</year>; <volume>9</volume>:<fpage>1467</fpage>&#8211;<lpage>1471</lpage>.<pub-id pub-id-type="pmid">19459817</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-6143.2009.02637.x</pub-id><pub-id pub-id-type="pmcid">PMC2742975</pub-id></mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adekunle</surname><given-names>RO</given-names></name><name name-style="western"><surname>Mehta</surname><given-names>AK</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Patzer</surname><given-names>RE</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>R</given-names></name></person-group>. <article-title>Early steps to kidney transplantation among persons with HIV and end-stage renal disease in ESRD network 6</article-title>. <source><italic toggle="yes">Transpl Infect Dis</italic></source><year>2022</year>; <volume>24</volume>:<fpage>e13767</fpage>.<pub-id pub-id-type="pmid">34813136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/tid.13767</pub-id><pub-id pub-id-type="pmcid">PMC8825692</pub-id></mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trish</surname><given-names>E</given-names></name><name name-style="western"><surname>Fiedler</surname><given-names>M</given-names></name><name name-style="western"><surname>Ning</surname><given-names>N</given-names></name><name name-style="western"><surname>Gascue</surname><given-names>L</given-names></name><name name-style="western"><surname>Adler</surname><given-names>L</given-names></name><name name-style="western"><surname>Lin</surname><given-names>E</given-names></name></person-group>. <article-title>Payment for dialysis services in the individual market</article-title>. <source><italic toggle="yes">JAMA Intern Med</italic></source><year>2021</year>; <volume>181</volume>:<fpage>698</fpage>&#8211;<lpage>699</lpage>.<pub-id pub-id-type="pmid">33749739</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamainternmed.2020.7372</pub-id><pub-id pub-id-type="pmcid">PMC7985814</pub-id></mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="book"><comment>System USRD. USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, Maryland: 2021</comment>.</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Waterman</surname><given-names>AD</given-names></name><name name-style="western"><surname>Robbins</surname><given-names>ML</given-names></name><name name-style="western"><surname>Peipert</surname><given-names>JD</given-names></name></person-group>. <article-title>Educating prospective kidney transplant recipients and living donors about living donation: practical and theoretical recommendations for increasing living donation rates</article-title>. <source><italic toggle="yes">Curr Transplant Rep</italic></source><year>2016</year>; <volume>3</volume>:<fpage>1</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="pmid">27347475</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40472-016-0090-0</pub-id><pub-id pub-id-type="pmcid">PMC4918088</pub-id></mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harbell</surname><given-names>J</given-names></name><name name-style="western"><surname>Terrault</surname><given-names>NA</given-names></name><name name-style="western"><surname>Stock</surname><given-names>P</given-names></name></person-group>. <article-title>Solid organ transplants in HIV-infected patients</article-title>. <source><italic toggle="yes">Curr HIV/AIDS Rep</italic></source><year>2013</year>; <volume>10</volume>:<fpage>217</fpage>&#8211;<lpage>225</lpage>.<pub-id pub-id-type="pmid">23893004</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11904-013-0170-z</pub-id><pub-id pub-id-type="pmcid">PMC5899895</pub-id></mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tourret</surname><given-names>J</given-names></name><name name-style="western"><surname>Guiguet</surname><given-names>M</given-names></name><name name-style="western"><surname>Lassalle</surname><given-names>M</given-names></name><name name-style="western"><surname>Grabar</surname><given-names>S</given-names></name><name name-style="western"><surname>Li&#232;vre</surname><given-names>L</given-names></name><name name-style="western"><surname>Isnard-Bagnis</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Access to the waiting list and to kidney transplantation for people living with HIV: a national registry study</article-title>. <source><italic toggle="yes">Am J Transplant</italic></source><year>2019</year>; <volume>19</volume>:<fpage>3345</fpage>&#8211;<lpage>3355</lpage>.<pub-id pub-id-type="pmid">31206243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ajt.15500</pub-id></mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stock</surname><given-names>PG</given-names></name></person-group>. <article-title>Strengths and weaknesses of using SRTR data to shape the management of the HIV-infected kidney transplant recipient</article-title>. <source><italic toggle="yes">Am J Transplant</italic></source><year>2017</year>; <volume>17</volume>:<fpage>3001</fpage>&#8211;<lpage>3002</lpage>.<pub-id pub-id-type="pmid">28858427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/ajt.14479</pub-id></mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glasheen</surname><given-names>WP</given-names></name><name name-style="western"><surname>Cordier</surname><given-names>T</given-names></name><name name-style="western"><surname>Gumpina</surname><given-names>R</given-names></name><name name-style="western"><surname>Haugh</surname><given-names>G</given-names></name><name name-style="western"><surname>Davis</surname><given-names>J</given-names></name><name name-style="western"><surname>Renda</surname><given-names>A</given-names></name></person-group>. <article-title>Charlson Comorbidity Index: ICD-9 update and ICD-10 translation</article-title>. <source><italic toggle="yes">Am Health Drug Benefits</italic></source><year>2019</year>; <volume>12</volume>:<fpage>188</fpage>&#8211;<lpage>197</lpage>.<pub-id pub-id-type="pmid">31428236</pub-id><pub-id pub-id-type="pmcid">PMC6684052</pub-id></mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>PS</given-names></name><name name-style="western"><surname>Knox</surname><given-names>J</given-names></name><name name-style="western"><surname>Jones</surname><given-names>J</given-names></name><name name-style="western"><surname>Taussig</surname><given-names>J</given-names></name><name name-style="western"><surname>Valentine Graves</surname><given-names>M</given-names></name><name name-style="western"><surname>Millett</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Understanding disparities in viral suppression among Black MSM living with HIV in Atlanta Georgia</article-title>. <source><italic toggle="yes">J Int AIDS Soc</italic></source><year>2021</year>; <volume>24</volume>:<fpage>e25689</fpage>.<pub-id pub-id-type="pmid">33821554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jia2.25689</pub-id><pub-id pub-id-type="pmcid">PMC8022103</pub-id></mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>QC</given-names></name><name name-style="western"><surname>Osypuk</surname><given-names>TL</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>NM</given-names></name><name name-style="western"><surname>Glymour</surname><given-names>MM</given-names></name><name name-style="western"><surname>Tchetgen Tchetgen</surname><given-names>EJ</given-names></name></person-group>. <article-title>Practical guidance for conducting mediation analysis with multiple mediators using inverse odds ratio weighting</article-title>. <source><italic toggle="yes">Am J Epidemiol</italic></source><year>2015</year>; <volume>181</volume>:<fpage>349</fpage>&#8211;<lpage>356</lpage>.<pub-id pub-id-type="pmid">25693776</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/kwu278</pub-id><pub-id pub-id-type="pmcid">PMC4339385</pub-id></mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Locke</surname><given-names>JE</given-names></name><name name-style="western"><surname>Shelton</surname><given-names>BA</given-names></name><name name-style="western"><surname>Olthoff</surname><given-names>KM</given-names></name><name name-style="western"><surname>Pomfret</surname><given-names>EA</given-names></name><name name-style="western"><surname>Forde</surname><given-names>KA</given-names></name><name name-style="western"><surname>Sawinski</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Quantifying sex-based disparities in liver allocation</article-title>. <source><italic toggle="yes">JAMA Surg</italic></source><year>2020</year>; <volume>155</volume>:<fpage>e201129</fpage>.<pub-id pub-id-type="pmid">32432699</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2020.1129</pub-id><pub-id pub-id-type="pmcid">PMC7240642</pub-id></mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>TN</given-names></name><name name-style="western"><surname>DeHovitz</surname><given-names>J</given-names></name><name name-style="western"><surname>Hirshfield</surname><given-names>S</given-names></name></person-group>. <article-title>Intersectional stigma and multi-level barriers to HIV testing among foreign-born Black men from the Caribbean</article-title>. <source><italic toggle="yes">Front Public Health</italic></source><year>2019</year>; <volume>7</volume>:<fpage>373</fpage>.<pub-id pub-id-type="pmid">31998675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fpubh.2019.00373</pub-id><pub-id pub-id-type="pmcid">PMC6965168</pub-id></mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arscott</surname><given-names>J</given-names></name><name name-style="western"><surname>Humphreys</surname><given-names>J</given-names></name><name name-style="western"><surname>Merwin</surname><given-names>E</given-names></name><name name-style="western"><surname>Relf</surname><given-names>M</given-names></name></person-group>. <article-title>That guy is gay and black. that's a red flag&#8217;. How HIV stigma and racism affect perception of risk among young Black men who have sex with men</article-title>. <source><italic toggle="yes">AIDS Behav</italic></source><year>2020</year>; <volume>24</volume>:<fpage>173</fpage>&#8211;<lpage>184</lpage>.<pub-id pub-id-type="pmid">31396765</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10461-019-02607-4</pub-id><pub-id pub-id-type="pmcid">PMC9093063</pub-id></mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baugher</surname><given-names>AR</given-names></name><name name-style="western"><surname>Whiteman</surname><given-names>A</given-names></name><name name-style="western"><surname>Jeffries</surname><given-names>WLT</given-names></name><name name-style="western"><surname>Finlayson</surname><given-names>T</given-names></name><name name-style="western"><surname>Lewis</surname><given-names>R</given-names></name><name name-style="western"><surname>Wejnert</surname><given-names>C</given-names></name></person-group>. <collab>NHBS Study Group</collab>. <article-title>Black men who have sex with men living in states with HIV criminalization laws report high stigma, 23 U.S. cities, 2017</article-title>. <source><italic toggle="yes">AIDS (London, England)</italic></source><year>2021</year>; <volume>35</volume>:<fpage>1637</fpage>&#8211;<lpage>1645</lpage>.<pub-id pub-id-type="pmid">34270489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAD.0000000000002917</pub-id><pub-id pub-id-type="pmcid">PMC9030111</pub-id></mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Murphy</surname><given-names>KA</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>JW</given-names></name><name name-style="western"><surname>Purnell</surname><given-names>TS</given-names></name><name name-style="western"><surname>Shaffer</surname><given-names>AA</given-names></name><name name-style="western"><surname>Haugen</surname><given-names>CE</given-names></name><name name-style="western"><surname>Chu</surname><given-names>NM</given-names></name><etal/></person-group>. <article-title>Association of socioeconomic status and comorbidities with racial disparities during kidney transplant evaluation</article-title>. <source><italic toggle="yes">Clin J Am Soc Nephrol</italic></source><year>2020</year>; <volume>15</volume>:<fpage>843</fpage>&#8211;<lpage>851</lpage>.<pub-id pub-id-type="pmid">32381582</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2215/CJN.12541019</pub-id><pub-id pub-id-type="pmcid">PMC7274281</pub-id></mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nonterah</surname><given-names>CW</given-names></name><name name-style="western"><surname>Gardiner</surname><given-names>HM</given-names></name></person-group>. <article-title>Pretransplant evaluation completion for Black/African American renal patients: two theoretical frameworks</article-title>. <source><italic toggle="yes">Patient Educ Counsel</italic></source><year>2020</year>; <volume>103</volume>:<fpage>988</fpage>&#8211;<lpage>998</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pec.2019.11.005</pub-id><pub-id pub-id-type="pmid">31733984</pub-id></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cervantes</surname><given-names>L</given-names></name><name name-style="western"><surname>Hasnain-Wynia</surname><given-names>R</given-names></name><name name-style="western"><surname>Steiner</surname><given-names>JF</given-names></name><name name-style="western"><surname>Chonchol</surname><given-names>M</given-names></name><name name-style="western"><surname>Fischer</surname><given-names>S</given-names></name></person-group>. <article-title>Patient navigation: addressing social challenges in dialysis patients</article-title>. <source><italic toggle="yes">Am J Kidney Dis</italic></source><year>2020</year>; <volume>76</volume>:<fpage>121</fpage>&#8211;<lpage>129</lpage>.<pub-id pub-id-type="pmid">31515136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.ajkd.2019.06.007</pub-id><pub-id pub-id-type="pmcid">PMC8118353</pub-id></mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>C</given-names></name><name name-style="western"><surname>Leon</surname><given-names>JB</given-names></name><name name-style="western"><surname>Sayre</surname><given-names>SS</given-names></name><name name-style="western"><surname>Marbury</surname><given-names>M</given-names></name><name name-style="western"><surname>Ivers</surname><given-names>M</given-names></name><name name-style="western"><surname>Pencak</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial</article-title>. <source><italic toggle="yes">Clin J Am Soc Nephrol</italic></source><year>2012</year>; <volume>7</volume>:<fpage>1639</fpage>&#8211;<lpage>1645</lpage>.<pub-id pub-id-type="pmid">22798540</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2215/CJN.11731111</pub-id><pub-id pub-id-type="pmcid">PMC3463214</pub-id></mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khosla</surname><given-names>N</given-names></name><name name-style="western"><surname>Gordon</surname><given-names>E</given-names></name><name name-style="western"><surname>Nishi</surname><given-names>L</given-names></name><name name-style="western"><surname>Ghossein</surname><given-names>C</given-names></name></person-group>. <article-title>Impact of a chronic kidney disease clinic on preemptive kidney transplantation and transplant wait times</article-title>. <source><italic toggle="yes">Prog Transplant</italic></source><year>2010</year>; <volume>20</volume>:<fpage>216</fpage>&#8211;<lpage>220</lpage>.<pub-id pub-id-type="pmid">20929105</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/152692481002000304</pub-id></mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bornemann</surname><given-names>K</given-names></name><name name-style="western"><surname>Croswell</surname><given-names>E</given-names></name><name name-style="western"><surname>Abaye</surname><given-names>M</given-names></name><name name-style="western"><surname>Bryce</surname><given-names>CL</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CH</given-names></name><name name-style="western"><surname>Good</surname><given-names>DS</given-names></name><etal/></person-group>. <article-title>Protocol of the KTFT-TALK study to reduce racial disparities in kidney transplant evaluation and living donor kidney transplantation</article-title>. <source><italic toggle="yes">Contemp Clin Trials</italic></source><year>2017</year>; <volume>53</volume>:<fpage>52</fpage>&#8211;<lpage>59</lpage>.<pub-id pub-id-type="pmid">27923612</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cct.2016.11.011</pub-id><pub-id pub-id-type="pmcid">PMC5274577</pub-id></mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boodram</surname><given-names>B</given-names></name><name name-style="western"><surname>Plankey</surname><given-names>MW</given-names></name><name name-style="western"><surname>Cox</surname><given-names>C</given-names></name><name name-style="western"><surname>Tien</surname><given-names>PC</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>MH</given-names></name><name name-style="western"><surname>Anastos</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study</article-title>. <source><italic toggle="yes">AIDS Patient Care STDS</italic></source><year>2009</year>; <volume>23</volume>:<fpage>1009</fpage>&#8211;<lpage>1016</lpage>.<pub-id pub-id-type="pmid">19909168</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/apc.2009.0175</pub-id><pub-id pub-id-type="pmcid">PMC2832643</pub-id></mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Achhra</surname><given-names>AC</given-names></name><name name-style="western"><surname>Sabin</surname><given-names>C</given-names></name><name name-style="western"><surname>Ryom</surname><given-names>L</given-names></name><name name-style="western"><surname>Hatleberg</surname><given-names>C</given-names></name><name name-style="western"><surname>Antonella d&#8217;Aminio</surname><given-names>M</given-names></name><name name-style="western"><surname>de Wit</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Body mass index and the risk of serious non-AIDS events and all-cause mortality in treated HIV-positive individuals: D: A: D Cohort Analysis</article-title>. <source><italic toggle="yes">J Acquir Immune Deficiency Syndr</italic></source><year>2018</year>; <volume>78</volume>:<fpage>579</fpage>&#8211;<lpage>588</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/QAI.0000000000001722</pub-id><pub-id pub-id-type="pmid">29771788</pub-id></mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandhu</surname><given-names>GS</given-names></name><name name-style="western"><surname>Khattak</surname><given-names>M</given-names></name><name name-style="western"><surname>Woodward</surname><given-names>RS</given-names></name><name name-style="western"><surname>Hanto</surname><given-names>DW</given-names></name><name name-style="western"><surname>Pavlakis</surname><given-names>M</given-names></name><name name-style="western"><surname>Dimitri</surname><given-names>N</given-names></name><name name-style="western"><surname>Goldfarb-Rumyantzev</surname><given-names>AS</given-names></name></person-group>. <article-title>Impact of substance abuse on access to renal transplantation</article-title>. <source><italic toggle="yes">Transplantation</italic></source><year>2011</year>; <volume>91</volume>:<fpage>86</fpage>&#8211;<lpage>93</lpage>.<pub-id pub-id-type="pmid">20966832</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/TP.0b013e3181fc8903</pub-id></mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>R</given-names></name><name name-style="western"><surname>Armstrong</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>C</given-names></name><name name-style="western"><surname>Day</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Neuberger</surname><given-names>JM</given-names></name></person-group>. <article-title>Alcohol and substance abuse in solid-organ transplant recipients</article-title>. <source><italic toggle="yes">Transplantation</italic></source><year>2013</year>; <volume>96</volume>:<fpage>1015</fpage>&#8211;<lpage>1024</lpage>.<pub-id pub-id-type="pmid">24025323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/TP.0b013e31829f7579</pub-id></mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Salter</surname><given-names>ML</given-names></name><name name-style="western"><surname>Orandi</surname><given-names>B</given-names></name><name name-style="western"><surname>McAdams-DeMarco</surname><given-names>MA</given-names></name><name name-style="western"><surname>Law</surname><given-names>A</given-names></name><name name-style="western"><surname>Meoni</surname><given-names>LA</given-names></name><name name-style="western"><surname>Jaar</surname><given-names>BG</given-names></name><etal/></person-group>. <article-title>Patient- and provider-reported information about transplantation and subsequent waitlisting</article-title>. <source><italic toggle="yes">J Am Soc Nephrol</italic></source><year>2014</year>; <volume>25</volume>:<fpage>2871</fpage>&#8211;<lpage>2877</lpage>.<pub-id pub-id-type="pmid">25168028</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1681/ASN.2013121298</pub-id><pub-id pub-id-type="pmcid">PMC4243357</pub-id></mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gander</surname><given-names>JC</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Ross</surname><given-names>K</given-names></name><name name-style="western"><surname>Wilk</surname><given-names>AS</given-names></name><name name-style="western"><surname>McPherson</surname><given-names>L</given-names></name><name name-style="western"><surname>Browne</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Notice of retraction and replacement. Gander <italic toggle="yes">et al.</italic> Association between dialysis facility ownership and access to kidney transplantation</article-title>. <source><italic toggle="yes">JAMA</italic></source><year>2019</year>; <volume>322</volume>:<fpage>957</fpage>&#8211;<lpage>973</lpage>.<pub-id pub-id-type="pmid">32315061</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2020.2328</pub-id><pub-id pub-id-type="pmcid">PMC7259465</pub-id></mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adler</surname><given-names>JT</given-names></name><name name-style="western"><surname>Xiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Weissman</surname><given-names>JS</given-names></name><name name-style="western"><surname>Rodrigue</surname><given-names>JR</given-names></name><name name-style="western"><surname>Patzer</surname><given-names>RE</given-names></name><name name-style="western"><surname>Waikar</surname><given-names>SS</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>TC</given-names></name></person-group>. <article-title>Association of public reporting of medicare dialysis facility quality ratings with access to kidney transplantation</article-title>. <source><italic toggle="yes">JAMA Netw Open</italic></source><year>2021</year>; <volume>4</volume>:<fpage>e2126719</fpage>.<pub-id pub-id-type="pmid">34559227</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2021.26719</pub-id><pub-id pub-id-type="pmcid">PMC8463939</pub-id></mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gander</surname><given-names>J</given-names></name><name name-style="western"><surname>Browne</surname><given-names>T</given-names></name><name name-style="western"><surname>Plantinga</surname><given-names>L</given-names></name><name name-style="western"><surname>Pastan</surname><given-names>SO</given-names></name><name name-style="western"><surname>Sauls</surname><given-names>L</given-names></name><name name-style="western"><surname>Krisher</surname><given-names>J</given-names></name><name name-style="western"><surname>Patzer</surname><given-names>RE</given-names></name></person-group>. <article-title>Dialysis facility transplant philosophy and access to kidney transplantation in the southeast</article-title>. <source><italic toggle="yes">Am J Nephrol</italic></source><year>2015</year>; <volume>41</volume>:<fpage>504</fpage>&#8211;<lpage>511</lpage>.<pub-id pub-id-type="pmid">26278585</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000438463</pub-id><pub-id pub-id-type="pmcid">PMC4560967</pub-id></mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Swaminathan</surname><given-names>S</given-names></name><name name-style="western"><surname>Sommers</surname><given-names>BD</given-names></name><name name-style="western"><surname>Thorsness</surname><given-names>R</given-names></name><name name-style="western"><surname>Mehrotra</surname><given-names>R</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y</given-names></name><name name-style="western"><surname>Trivedi</surname><given-names>AN</given-names></name></person-group>. <article-title>Association of Medicaid expansion with 1-year mortality among patients with end-stage renal disease</article-title>. <source><italic toggle="yes">JAMA</italic></source><year>2018</year>; <volume>320</volume>:<fpage>2242</fpage>&#8211;<lpage>2250</lpage>.<pub-id pub-id-type="pmid">30422251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2018.16504</pub-id><pub-id pub-id-type="pmcid">PMC6417808</pub-id></mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harhay</surname><given-names>MN</given-names></name><name name-style="western"><surname>McKenna</surname><given-names>RM</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>SM</given-names></name><name name-style="western"><surname>Ranganna</surname><given-names>K</given-names></name><name name-style="western"><surname>Mizrahi</surname><given-names>LL</given-names></name><name name-style="western"><surname>Guy</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Association between Medicaid expansion under the affordable care act and preemptive listings for kidney transplantation</article-title>. <source><italic toggle="yes">Clin J Am Soc Nephrol</italic></source><year>2018</year>; <volume>13</volume>:<fpage>1069</fpage>&#8211;<lpage>1078</lpage>.<pub-id pub-id-type="pmid">29929999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2215/CJN.00100118</pub-id><pub-id pub-id-type="pmcid">PMC6032587</pub-id></mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Byrne</surname><given-names>P</given-names></name><name name-style="western"><surname>Willmore</surname><given-names>J</given-names></name><name name-style="western"><surname>Bryan</surname><given-names>A</given-names></name><name name-style="western"><surname>Friedman</surname><given-names>DS</given-names></name><name name-style="western"><surname>Hendriks</surname><given-names>A</given-names></name><name name-style="western"><surname>Horvath</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Nondisclosure prosecutions and population health outcomes: examining HIV testing, HIV diagnoses, and the attitudes of men who have sex with men following nondisclosure prosecution media releases in Ottawa, Canada</article-title>. <source><italic toggle="yes">BMC public health</italic></source><year>2013</year>; <volume>13</volume>:<fpage>94</fpage>.<pub-id pub-id-type="pmid">23369031</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1471-2458-13-94</pub-id><pub-id pub-id-type="pmcid">PMC3637096</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>